IssuerAnnouncementDetailsV2Portlet
Actions
Dr. Sulaiman Al Habib Medical Services Group announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 2,521.41 | 2,306.87 | 9.3 | 2,486.49 | 1.404 |
| Gross Profit (Loss) | 877.33 | 783.64 | 11.955 | 868.16 | 1.056 |
| Operational Profit (Loss) | 556.07 | 510.57 | 8.911 | 534.18 | 4.097 |
| Net profit (Loss) | 550.95 | 489.27 | 12.606 | 525.01 | 4.94 |
| Total Comprehensive Income | 551.89 | 505.65 | 9.144 | 502.15 | 9.905 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Share Holders Equity (After Deducting the Minority Equity) | 6,634.88 | 6,058.84 | 9.507 |
| Profit (Loss) per Share | 1.57 | 1.4 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Percentage of the capital (%) | Amount | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenues: for Q1 – 2024, revenues grew by 9.30%, reaching SAR 2,521.41 million, with an increase of SAR 214.54 million as compared to SAR 2,306.87 million in the corresponding quarter of the previous year, as a result of the growth in all group operating segments. Revenue growth for Q1 – 2024 was mainly driven by growth in both the hospital and pharmacy segments. The increase in the hospital segment’s number of patients has a positive correlation with the pharmacy segment sales increase compared to the similar quarter of the previous year. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | EBITDA for Q1 – 2024 increased by 9.36%, reaching SAR 681.12 million. The group maintained the same EBITDA margin at 27.01%, compared to 27.00% in the corresponding quarter of the previous year. Net Income for Q1 – 2024 increased by 12.61% to reach SAR 550.95 million, with an improved net income margin reaching 21.85% versus 21.21% for the corresponding quarter of the previous year. The increase was mainly driven by revenue growth due to the increase in the number of patients. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Revenue grew 1.40% during Q1 – 2024 compared to the previous quarter, Q4 – 2023, driven by the growth in the number of patients. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net income attributable to the company’s shareholders Increased by 4.94% in Q1 – 2024 compared to the previous quarter Q4–2023, which was mainly due to the growth in revenue. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | na |
| Reclassification of Comparison Items | na |
| Additional Information | na |
| Attached Documents |  |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 311.4
Net Change -5.4 (-1.7%)
Value Traded (Sar) 55,879,107.2
Volume Traded 178,824
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions